The FDA has approved CYTALUX for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions, according to…
Cancer
-
-
Agrochemicals
Fortis Escorts Faridabad introduces Cryotechnique for lung cancer treatment.
by adminby adminSUMMARY: Faridabad`s Fortis Escorts Hospital is the first hospital to introduce the latest, state-of-the-art technology in the field of interventional pulmonology, the…
-
Agrochemicals
NATCO Pharma launches Tipanat (Trifluridine + Tipiracil) Tablets in India, for the Treatment of Advanced Colorectal and Gastric Cancer.
by adminby adminKEYPOINTS: Natco Pharma Limited has launched a novel fixed-dose combination of Trifluridine + Tipiracil for the first-time in India under the brand…
-
Agrochemicals
Kerala’s Native herb ‘Manathakkali’ (Solanum nigrum) Approved for Liver Cancer, Research gets US FDA Nod.
by adminby adminKEYPOINTS: ‘Manathakkali’ (Black nightshade or Solanum nigrum), a berry-bearing shrub found in the backyard, is traditionally known for its medicinal value. Two scientists…
-
A research project conducted by the Rajiv Gandhi Centre for Biotechnology (RGCB) here has found that the berry-bearing black nightshade shrub could…
-
ChinaPharma Science & Research
Green Signal for Kintor Pharma, PD-L1/TGF-β dual-targeting antibody (GT90008) for Tumour Clinical Trail from China NMPA
by adminby adminKintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the clinical trial of…
-
Global MarketPharma Science & Research
Himalayan caterpillar fungus possessing Anti- Cancer Activity Shows Potential and Promising Results in Phase 1 Clinical Trial
by adminby adminSynopsis– The chemotherapy has been developed from a molecule found in Himalayan caterpillar fungus and is still in the experimental testing stages. The…
-
Active Pharmaceutical Ingredients (API)Chugai Pharmaceuticals and Oncolys BioPhamaCompaniesTelomelysin
Oncolys BioPharma and Chugai Pharmaceuticals agree to Terminate Exclusive License Agreement on Oncolytic Viral Immunotherapy, OBP-301(Telomelysin)
by adminby adminKeypoints: Chugai, Oncolys BioPharma agree to terminate exclusive license agreement on oncolytic viral immunotherapy, OBP-301 The effective date of the termination will…
-
AbemaciclibActive Pharmaceutical Ingredients (API)
Agilent Technologies’ Ki-67 IHC MIB-1 PharmDx assay has been approved by the FDA for use as a Companion Diagnostic to Eli Lilly’s Abemaciclib, or Verzenio.
by adminby adminKEYPOINTS The FDA has given the Ki-67 IHC MIB-1 pharmDx assay a companion diagnostic approval for detecting Ki-67 expression in patients with…
-
CabometryxOpdivo
Scotland Backed Amalgamation of Opdivo & Cabometryx for Treatment of Advanced Renal Carcinoma
by adminby adminKey Points – SMC approved Combination of Opdivo (Nivolumab) plus Cabometryx (Cabozantinib) for treatment of Advanced Renal Carcinoma In a Phase III…